Global X HealthTech ETF (NASDAQ:HEAL) Short Interest Down 64.0% in June

Global X HealthTech ETF (NASDAQ:HEAL) saw a large decline in short interest in June. As of June 30th, there was short interest totaling 13,534 shares, a decline of 64.0% from the June 15th total of 37,633 shares. Approximately 1.3% of the company’s shares are sold short. Based on an average trading volume of 8,169 shares, the days-to-cover ratio is presently 1.7 days.

Global X HealthTech ETF Price Performance

Global X HealthTech ETF stock opened at $28.24 on Monday. The firm has a market cap of $29.93 million, a PE ratio of 42.80 and a beta of 1.10. Global X HealthTech ETF has a 52-week low of $23.00 and a 52-week high of $33.59. The company’s 50 day moving average is $26.01 and its two-hundred day moving average is $26.60.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Glenmede Investment Management LP purchased a new stake in Global X HealthTech ETF during the 3rd quarter worth about $31,000. Banque Cantonale Vaudoise purchased a new stake in shares of Global X HealthTech ETF during the third quarter worth approximately $37,000. Royal Bank of Canada increased its stake in shares of Global X HealthTech ETF by 39.4% during the first quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock worth $62,000 after buying an additional 736 shares during the period. EverSource Wealth Advisors LLC raised its holdings in Global X HealthTech ETF by 26,522.2% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,396 shares of the company’s stock valued at $70,000 after acquiring an additional 2,387 shares in the last quarter. Finally, Farther Finance Advisors LLC acquired a new stake in Global X HealthTech ETF in the fourth quarter valued at approximately $111,000.

Global X HealthTech ETF Company Profile

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.